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Abstract
Ciliary accumulation of signaling proteins must result from a rate of ciliary entry that exceeds ciliary exit, but approaches for
distinguishing ciliary entry vs. exit are lacking. Using a photoconvertible fluorescent protein tag, we establish an assay that
allows a separate but simultaneous examination of ciliary entry and exit of the Hedgehog signaling protein Smoothened in
individual cells. We show that KAAD-cyclopamine selectively blocks entry, whereas ciliobrevin interferes initially with exit
and eventually with both entry and exit of ciliary Smoothened. Our study provides an approach to understanding regulation
of ciliary entry vs. exit of Hedgehog signaling components as well as other ciliary proteins.
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signal to Ptc, thus unleashing Smo activity and initiating a series of
intracellular events that lead to changes in gene transcription.
Recent studies have highlighted the importance of the primary
cilium in transduction of mammalian Hh signals. Smo and other
Hh pathway components in mammalian cells traffic through the
primary cilium and accumulate upon Hh stimulation and Ptc
inactivation [8–13]. Small molecules that either activate or
inactivate Smo can also modulate signaling activity and ciliary
localization of Smo [3,14]. Given that accumulation of Smo in the
primary cilium is one of the earliest hallmarks of Hh pathway
activation, understanding regulation of Hh signal transduction
depends critically on unveiling the molecular mechanism of Smo
accumulation in the primary cilium.
Whereas ciliary entry has been emphasized as a critical point of
regulation, the findings that Smo continuously shuttles into and
out of the cilium in unstimulated cells [11,15] and that levels of
ciliary Smo eventually decrease once stimulation is terminated
leave open the possibility that either entry or exit rates could be the
target for regulation upon pathway engagement. Establishment of
assays to separately monitor Smo ciliary entry and exit therefore
could illuminate the general mechanism underlying protein
accumulation in the primary cilium as well as shed light into
how the Hh signaling pathway is regulated.
Here, we fuse a photoconvertible fluorescent protein, mEos2
[16], to the C-terminus of Smo (Smo-mEos2) and establish a livecell imaging assay that allows a simultaneous examination of
ciliary entry and exit of Smo in individual cells. Using this assay,
we find that activated Smo enters and exits the cilium continuously

Introduction
The primary cilium, a microtubule-based organelle about 5 mm
in length and 200 nm in diameter, projects from the surface of
vertebrate cells to sense and interpret a variety of extracellular
signals [1]. Previous work has suggested that the dynamic
movement of receptors and other proteins into and out of cilia
regulates the activity of signaling complexes that ultimately trigger
responses in the cell [2]. It has been proposed that ciliary
accumulation of signaling proteins results from a rate of ciliary
entry that exceeds the rate of ciliary exit [3]. An understanding of
signaling receptor trafficking into cilia is now emerging [4];
however, the mechanisms that underlie membrane protein
removal from cilia and the regulation of this trafficking step
remain largely unexplored. The major challenges arise not just
from the small size of the primary cilium, but also from the
difficulty of separately evaluating ciliary entry and exit of proteins
that traffic through the primary cilium. In this context, development of new assays that can distinguish ciliary entry and exit are
crucial to progress in understanding regulation of ciliary trafficking.
The Hedgehog (Hh) signaling pathway organizes pattern
formation in a variety of embryonic tissues and functions postembryonically in homeostatic processes. Hh pathway dysfunction
thus can lead to birth defects such as holoprosencephaly (HPE) [5]
or proliferative disorders such as the growth of malignant tumors
[6]. The quiescent state of the Hh signaling pathway is maintained
by Patched (Ptc) inhibition of Smoothened (Smo) [7]. This
inhibition is lifted by binding of the extracellular Hh protein
PLOS ONE | www.plosone.org
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ciliary retention half-life of Smo-mEos2 in SAG-treated cells.
Therefore, exit of Smo-mEos2 accounts for most, if not all, of its
turnover in the primary cilium of SAG-treated cells. Interestingly,
we measured a half-life of total Smo-mEos2 protein on the order
of 2 hours in cells not treated with SAG (Fig. S3), suggesting that
SAG binding to Smo may increase its stability, which is consistent
with previous studies showing that SAG-binding to Smo may aid
in its maturation [23].

with a ciliary retention half-life of approximately two hours. We
also find that the small molecule KAAD-cyclopamine selectively
blocks ciliary entry of Smo, whereas long-term exposure to
ciliobrevin eventually interferes with both the ciliary entry and exit
of Smo. Our study provides an approach to understanding the
separate regulation of ciliary entry vs. exit of signaling proteins
within and beyond the Hh pathway.

Results and Discussion
Ciliobrevin A reduced both ciliary entry and exit of SmomEos2

Ciliary entry and exit of Smo-mEos2 in SAG-treated cells
To simultaneously monitor how the Hh pathway protein Smo
enters and exits the primary cilium, we have fused the
photoconvertible fluorescent protein mEos2 [16] to the Cterminus of Smo, which permits normal function of the resulting
chimeric Smo-mEos2 protein upon introduction into Smo2/2
cells (Fig. S1). We generated an NIH 3T3 cell line stably
expressing the Smo-mEos2 protein (NIH 3T3/Smo-mEos2), in
which the Smo-mEos2 accumulated within cilia in response to Shh
or SAG, a small molecule that binds directly to Smo (Fig. 1a–d).
The NIH 3T3/Smo-mEos2 cell line shows comparable response
to ShhN or SAG as in NIH 3T3 cells (Fig. 1e).
We first treated the NIH 3T3/Smo-mEos2 cells with SAG for
24 hours to allow Smo-mEos2 to accumulate in primary cilia. The
cilium highlighted by Smo-mEos2 was selected as a region-ofinterest (ROI) for photoconversion with a 405-nm laser. Upon
photoconversion, mEos2 shifts from a peak excitation at 506 nm
and peak emission at 519 nm (Smo-mEos2 native, hereafter SmomEos2N), similar to GFP, to a peak excitation at 573 nm and peak
emission at 584 nm (Smo-mEos2 photoconverted, hereafter SmomEos2P), similar to RFP. Both Smo-mEos2N and Smo-mEos2P
were subsequently monitored through time-lapse imaging. Thus,
an increase of green fluorescence within the cilium reflects SmomEos2N entering from the cell body, while a decrease of red
fluorescence in the cilium reveals Smo-mEos2P exiting the cilium.
In previous photobleaching experiments, a significant recovery
of ciliary fluorescence for the intracellular transport protein IFT88
was detected several minutes after photobleaching [17]. In
contrast, we detected little or no recovery of Smo-mEos2N (ciliary
entry) 10 minutes after photoconversion (Fig. S2). Similarly, no
noticeable reduction of Smo-mEos2P (ciliary exit) was detected
within a similar time frame (Fig. S2).
This delay in recovery of ciliary Smo-mEos2N relative to IFT88
may arise from the slower kinetics of Smo entry into the cilium,
whether by limited lateral diffusion [18] of membrane proteins
from the plasma membrane into the primary cilium, proposed to
result from a diffusion barrier at its base [17], or alternatively from
the relatively slow process of entry via fusion of internal vesicles
[19]. We therefore increased the time-lapse imaging interval and
first detected an increased level of Smo-mEos2N in the cilium
around 25 minutes after photoconversion. A slight decrease of
Smo-mEos2P was also noticed within a similar interval. Using this
assay, we observed that Smo-mEos2 proteins constantly enter and
exit the cilium in the presence of SAG, with a ciliary retention
half-life of approximately 2 hours (Fig. 2).
Given that neither electron microscopic images nor proteome
analyses have revealed the presence of proteasomes in cilia [20–
22], it is unlikely that the observed decrease of Smo-mEos2P is due
to its degradation within the primary cilium. We further examined
the possible role of protein degradation in turnover of Smo-mEos2
by measuring the stability of Smo-mEos2 protein in cells treated
with cycloheximide to block new protein synthesis. We found that
Smo-mEos2 in the presence of SAG has a half-life of more than
6 hours (Fig. S3), three-fold longer than the approximate 2-hour
PLOS ONE | www.plosone.org

It was previously reported that inactive Smo accumulated in
primary cilia of cells with disrupted retrograde intraflagellar
transport [11,15]. We reproduced this ciliary accumulation of Smo
in the absence of Hh ligands or Smo agonists in NIH 3T3/SmomEos2 cells by adding a low level of ciliobrevin A (CBA) [24], a
specific small molecule inhibitor of the minus end-directed
microtubule motor cytoplasmic dynein. After 24 hours of treatment with 10 mM CBA, the proportion of ciliated cells was
dramatically reduced to about 30% of the entire cell population
(Fig. S4C). Smo-mEos2 was detected in more than 70% of these
ciliated cells (Fig. S4A, B, D).
To assay the ciliary entry and exit kinetics of inactive Smo
caused by disrupted retrograde intraflagellar transport, we treated
the NIH 3T3/Smo-mEos2 cells with 10 mM CBA for 24 hours to
allow Smo-mEos2 to accumulate in primary cilia. The cilium
highlighted by Smo-mEos2N was selected for photoconversion and
both the native and the photoconverted species of Smo-mEos2
were subsequently monitored through time-lapse imaging. When
compared with SAG-treated cells, we noticed a much slower entry
and exit of both native and photoconverted Smo-mEos2 in the
cilium of cells treated with CBA (Fig. 3). Specifically, at
200 minutes after photoconversion, about 80% of Smo-mEos2P
remained in the cilium of CBA-treated cells, whereas less than
20% was left in the cilium of SAG-treated cells. Similarly,
compared to more than 80% recovery of Smo-mEos2N in the
cilium of cells treated with SAG, about 20% of Smo-mEos2N was
detected in the cilium of CBA-treated cells.
These results suggest that defects in retrograde intraflagellar
transport dramatically slowed down both ciliary entry and exit of
Smo. A previous study has demonstrated that ciliobrevins are
specific small molecule inhibitors of cytoplasmic dynein, and have
no significant effect on kinesin-dependent anterograde microtubule sliding even at a concentration 10 times higher than was used
in our experiment [24]. The reduced ciliary exit rate of Smo could
be explained as a direct result of the defects in retrograde
intraflagellar transport caused by CBA. The reduced ciliary entry
rate of Smo in contrast is likely to be an indirect effect of CBA
resulting from a cumulative general disruption of ciliary trafficking
over time; initial entry is unlikely to be affected, as increase in
ciliary Smo was noted when the NIH 3T3/Smo-mEos2 cells were
pretreated with SAG for 24 hours, followed by photoconversion
and time-lapse imaging immediately after introducing CBA (Fig.
S5).

KAAD-cyclopamine selectively reduces ciliary entry of
Smo-mEos2
Ciliary accumulation of Smo has been reported to occur upon
treatment with cyclopamine [3]. Curiously, although we and
others have confirmed this effect [11,19,25], we failed to see Smo
accumulation upon treatment with KAAD-cyclopamine (data not
shown), a highly potent derivative of cyclopamine [23,26]. The
different effects of cyclopamine and KAAD-cyclopamine on Smo
2

August 2014 | Volume 9 | Issue 8 | e104070

Simultaneous Measurement of Ciliary Entry and Exit of Smoothened

Figure 1. A Hh- and SAG-responsive NIH 3T3/Smo-mEos2 cell line. (A–C) The NIH 3T3/Smo-mEos2 cells were incubated in the absence or
presence of SAG or ShhN, and then fixed and stained with anti-acetylated tubulin (primary cilium, red) and DAPI (nucleus, blue). Smo-mEos2 was
detected in the primary cilium only when the cells were treated with 100 nM SAG (B) or ShhN (C), but not in the un-treated cells (A). The boxed region
in each main panel was viewed on the right in separated red, green channels, and shifted overlays. Scale bar, 5 mm. (D) Mean intensity of Smo-mEos2
fluorescence in cilia of NIH 3T3/Smo-mEos2 cells treated with ShhN or SAG. Each point shows the mean 6 SD of fluorescence from 10–20 cilia. (E) The
NIH 3T3/Smo-mEos2 cells were incubated in the absence or presence of ShhN or SAG. The mRNA was extracted 48 hours later and real-time
quantitative RT-PCR was performed to measure the mRNA level of Gli1.
doi:10.1371/journal.pone.0104070.g001

induced degradation of Smo; (ii) decreased ciliary entry rate of
Smo; or (iii) accelerated ciliary exit of Smo. To distinguish these
possibilities, we first used cycloheximide chase experiments to
compare the stability of total Smo-mEos2 protein levels in cells
treated with SAG vs. SAG followed by addition of KAADcyclopamine. Adding KAAD-cyclopamine in cells pre-treated with
SAG did not decrease the half-life of Smo-mEos2 (Fig. S8), and
instead caused a slight increase in total Smo-mEos2 protein levels
as compared to cells treated with SAG alone. We therefore ruled
out a destabilizing effect of KAAD-cyclopamine as the cause of
Smo-mEos2 ciliary loss.
To test for KAAD-cyclopamine triggered changes on ciliary
trafficking of Smo-mEos2 we used the photoconversion assay.
NIH 3T3/Smo-mEos2 cells were pre-treated with 100 nM SAG
for 24 hours to allow Smo-mEos2 to accumulate in primary cilia,
and 300 nM KAAD-cyclopamine was added to cells followed by
photoconversion of ciliary Smo-mEos2. Both Smo-mEos2N and
Smo-mEos2P were subsequently monitored through time-lapse

ciliary localization were also found when using our NIH 3T3/
Smo-mEos2 cells (Fig. S6). Furthermore, we found in a set of timeseries experiments that treatment with 300 nM KAAD-cyclopamine reversed the ciliary accumulation of Smo-mEos2 that is
induced by pre-treatment with 100 nM SAG. Specifically, we
started to detect reduction of ciliary Smo-mEos2 about 4 hours
after adding KAAD-cyclopamine, and ciliary Smo decreased by
more than 90% within an additional 8 hours (Fig. 4). To rule out
the possibility that the KAAD-cyclopamine-associated removal of
ciliary Smo-mEos2 is an artifact due to the mEos2 tag on Smo, we
tested the effect of KAAD-cyclopamine on endogenous Smo in
NIH 3T3 cells, and found that KAAD-cyclopamine eliminated
SAG-induced ciliary accumulation of endogenous Smo (Fig. S7).
These observations indicate that the effect of KAAD-cyclopamine
on Smo-mEos2 indeed reflects the behavior of wild type Smo
proteins.
The observed reversal of ciliary accumulation of Smo-Eos2
could be explained in several ways: (i) KAAD-cyclopaminePLOS ONE | www.plosone.org
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Figure 2. Monitoring ciliary entry and exit of Smo-mEos2 in SAG-treated cells. (A) Schematic diagram of drug treatment and
photoconversion of NIH 3T3/Smo-mEos2 cells. (B) Time-lapse images taken at a 25 min interval showing both Smo-mEos2N (green) and Smo-mEos2P
(red) from a representative cilium before and after photoconversion at 405 nm. Scale bar, 1 mm. (C) Kinetics of fluorescence recovery of Smo-mEos2N
(green) and fluorescence decrease of Smo-mEos2P (red) in the whole cilium of SAG treated cells. Each point shows the mean 6 SEM of fluorescence
from 5 cilia.
doi:10.1371/journal.pone.0104070.g002

the finding that blocked ciliary entry of Smo by KAADcyclopamine prevents the accumulation triggered by treatment
with CBA alone reinforces our conclusion that CBA does not
initially block ciliary entry of Smo, and that the entry block we
measured after 24 hours of treatment with CBA indeed results
from a cumulative overall defect in ciliary trafficking.
Ott and Lippincott-Schwartz [27] recently showed that
photoconversion could be used to highlight and track the
movement of a subset of molecules within the primary cilium,
and Ye et al. tracked the movement of single molecules within the
cilium [28]. In both of these studies the major focus was on
tracking individual molecules or complexes within the cilium by
photoconverting or labeling a small subset of the molecules. Our
study differs in that we completely photoconverted a ciliary
protein, Smo, in order to measure the ensemble average of ciliary
entry and exit kinetics. This required relatively long intervals for
time-lapse imaging as well as a long imaging duration in order to

imaging. About 200 minutes after photoconversion, we observed a
dramatic reduction of Smo-mEos2P in the cilium of cells exposed
to KAAD-cyclopamine, which is similar to the ciliary exit rate of
Smo-mEos2 in the cilium of cells treated with SAG alone. In
contrast to the normal ciliary exit rate indicated by Smo-mEos2P,
the ciliary entry rate indicated by recovery of Smo-mEos2N in the
cilium of KAAD-cyclopamine treated cells was much slower: thus,
at the time when Smo-mEos2N was almost completely recovered
in the cilium of SAG treated cells, less than 20% recovery was
achieved by Smo-mEos2N in cells treated with SAG and KAADcyclopamine (Fig. 5). These data thus suggest that KAADcyclopamine-induced loss of Smo from the cilium of SAG treated
cells is due to decreased ciliary entry rather than accelerated ciliary
exit. Additionally, KAAD-cyclopamine blocked the ciliary accumulation of Smo-mEos2 triggered by CBA (Fig. S9). This result
supports the conclusion that KAAD-cyclopamine decreases ciliary
entry of Smo-mEos2 even in the absence of agonists. In addition,
PLOS ONE | www.plosone.org
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Figure 3. Monitoring ciliary entry and exit of Smo-mEos2 in CBA-treated cells. (A) Schematic diagram of drug treatment and
photoconversion of NIH 3T3/Smo-mEos2 cells. (B) Time-lapse images taken at a 25 min interval showing both Smo-mEos2N (green) and Smo-mEos2P
(red) from a representative cilium before and after photoconversion at 405 nm. Scale bar, 1 mm. (C) Kinetics of Smo-mEos2N recovery (green) and
Smo-mEos2P decrease (red) in the whole cilium from CBA-treated cells. The kinetics of Smo-mEos2N recovery (open circle) and Smo-mEos2P decrease
(open square) in the cilium of SAG treated cells were included for comparison. Each point shows the mean 6 SEM of fluorescence from 5 cilia. (D)
Quantification of Smo-mEos2N recovery (green) and Smo-mEos2P decrease (red) in the cilium of SAG and CBA treated cells. Asterisks show statistically
significant differences (Smo-mEos2N recover, P = 0.00059; Smo-mEos2P decrease, P = 0.0035). Error bars show SD, n = 5.
doi:10.1371/journal.pone.0104070.g003

capture the slow overall kinetics of ciliary entry and exit of
transmembrane proteins such as Smo.
In summary, we have established a live-cell imaging assay that
allows a separate but simultaneous examination of ciliary entry
and exit of Smo in individual cells. Using this assay, we find that
activated Smo constantly enters and exits the cilium with a ciliary
retention half-life of approximately two hours. We also find that
small molecules such as KAAD-cyclopamine selectively block
ciliary entry of Smo, whereas CBA interferes initially with ciliary
exit but eventually with both ciliary entry and exit of Smo. Our
study provides an approach to understanding regulation of ciliary
entry vs. exit of Hedgehog pathway components, as well as other
ciliary proteins.

Methods
Cell culture, Constructs and Reagents
mEos2 (Addgene plasmid 20341) was fused to mouse Smo at the
C terminus to generate the Smo-mEos2 construct. The stable cell
line expressing Smo-mEos2 was produced by site-specific recombination into a single site in the genome of 3T3 cells using the FlpIn system (Invitrogen). We obtained SAG from Enzo Life
Sciences, KAAD-cyclopamine from EMD Chemicals, CBA,
Cycloheximide and DMSO were from Sigma. ShhN conditioned
medium were prepared as previously described [29].

Antibodies
Antibodies were used at the following concentrations: rabbit
anti-Smo antibody [11] 1:1000, mouse monoclonal anti-acetylated

PLOS ONE | www.plosone.org
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Figure 4. KAAD-cyclopamine blocks SAG induced accumulation of Smo-mEos2 in cilia. (A) Schematic diagram of drug treatment, fixation,
and staining of NIH 3T3/Smo-mEos2 cells. (B–C) NIH 3T3/Smo-mEos2 cells were incubated with medium containing 100 nM SAG for 24 h, and then
treated with additional 300 nM KAAD-cyclopamine or DMSO (control) for another 24 h followed by fixation, antibody staining, and imaging.
Additional KAAD-cyclopamine inhibits accumulation of Smo-mEos2 in cilia of cells induced by SAG (compare B and C). The boxed region in each main
panel was viewed on the right in separated red, green channels, and shifted overlays. Scale bar, 5 mm. (D) Mean intensity of Smo-mEos2 fluorescence
in cilia of SAG-pre-treated NIH 3T3/Smo-mEos2 cells with addition of DMSO or KAAD-cyclopamine. Each point shows the mean 6 SEM of
fluorescence from 10–20 cilia.
doi:10.1371/journal.pone.0104070.g004

tubulin antibody (Sigma) 1:2000, mouse anti-beta tubulin (Developmental Studies Hybridoma Bank) 1:5000, secondary antibodies
(Jackson ImmunoResearch Laboratories) 1:500.

Gli reporter assays
NIH 3T3/Smo-mEos2 cells were plated at 5–96104 cells/well
of 24-well plates and transfected the next day using FuGENE HD
(Promega) with Gli-luciferase reporter, control pRL-SV40 renilla
luciferase, and other DNA constructs as indicated. After cells
reached confluence in about 2 days, they were shifted to 0.5%
serum medium and incubated 24 h with ShhN.

RT-PCR
NIH 3T3/Smo-mEos2 cells were grown to reach confluence.
The cells were then shifted to 0.5% serum medium and incubated
24 h with or without ShhN or SAG as described. RNA from the
cells was extracted and purified using the RNeasy Mini Kit from
Qiagen. One-step RT-PCR was performed using the OneStep
RT-PCR kit (Qiagen) on the 7300 Real-Time PCR System
(Applied Biosystems). Non-linear regression analysis for curve
fitting was performed using GraphPad Prism software.
PCR primers were as follows: 59- AAGGAATTCGTGTGCCATTGGG-39 and 59- ACATGTAAGGCTTCTCACCCGT-39
for Gli1, 59- CGTGATTAGCGATGATGAACCAGG-39 and 59CATCTCGAGCAAGTCTTTCAGTCC-39 for HPRT1 (internal reference).

Immunofluorescence and Quantification of Microscopic
images
Cells were fixed in 4% formaldehyde for 10 min, and then
washed 3 times with PBS. Fixed cells were placed in blocking
solution (PBS with 1% normal goat serum and 0.1% Triton X100) for 30 min. Primary antibodies were diluted in blocking
solution and used to stain cells for 1 h at room temperature. After
3 washes in PBS, secondary antibodies and DAPI (Invitrogen)
were added in blocking solution at a dilution of 1:500 for 1 h at
room temperature. The samples were mounted in VECTASHIELD Mounting Medium (Vector Laboratories) for microscopy. Microscopy was performed on a Leica spinning disc confocal
microscope SD6000. Images were taken with a 636 objective. All
analysis was performed using ImageJ, as described previously [3].
For the quantitative analysis of Smo-mEos2 levels in primary cilia,
all images used for comparisons within an experiment were
obtained with identical settings on the microscope and then used
for quantification without any manipulation. A mask was
constructed by manually outlining cilia in the image taken in the
acetylated-tubulin channel. This mask was then applied to the

Cycloheximide chase and Western blot analysis
NIH 3T3/Smo-mEos2 cells were grown to confluence and
shifted to 0.5% serum medium and treated with DMSO or SAG
for 24 h before the addition of cycloheximide (in the continued
presence of DMSO, SAG, or KAAD-cyclopamine as described in
related experiments) to block protein synthesis for the indicated
periods of time. Cells were lysed and the level of total Smo-mEos2
was measured by immunoblotting.

PLOS ONE | www.plosone.org
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Figure 5. Monitoring ciliary entry and exit of Smo-mEos2 in KAAD-cyclopamine-treated cells. (A) Schematic diagram of drug treatment
and photoconversion of NIH 3T3/Smo-mEos2 cells. (B) Time-lapse images taken at a 25 min interval showing both Smo-mEos2N (green) and SmomEos2P (red) from a representative cilium before and after photoconversion at 405 nm. Scale bar, 1 mm. (C) Kinetics of Smo-mEos2N recovery (green)
and Smo-mEos2P decrease (red) in the whole cilium from KAAD-cyclopamine-treated cells. The kinetics of Smo-mEos2N recovery (open circle) and
Smo-mEos2P decrease (open square) in the cilium of SAG treated cells were included for comparison. Each point shows the mean 6 SEM of
fluorescence from 5 cilia. (D) Quantification of Smo-mEos2N recovery (green) and Smo-mEos2P decrease (red) in the cilium of SAG and KAADcyclopamine treated cells. Asterisks show statistically significant differences (Smo-mEos2N recovery, P = 0.0059; Smo-mEos2P decrease, P = 0.86). Error
bars show SD, n = 5.
doi:10.1371/journal.pone.0104070.g005

confocal microscope equipped with the Zen 2009 software and an
environmental control chamber (5% CO2, 37uC and humidity). A
cilium was selected and focused on in the green channel (SmomEos2N), which was outlined as the region of interest for
photoconversion. Smo-mEos2 conversion was achieved by the
scanning of outlined primary cilium with a 405 nm laser (2%
intensity) for 10 iterations using a 636 objective and 46 Zoom.
Time-lapse recordings of both Smo-mEos2N channel (excitation
with 488/emission BP505–550) and Smo-mEos2P channel (excitation with 561/emission LP575) were performed every 1 or
25 min as described. Images were exported from Zen 2009 and
analyzed with ImageJ. For the quantitative analysis of Smo-mEos2
levels in primary cilia, all images used for comparisons within an
experiment were obtained with identical settings on the microscope and then used for quantitation without any manipulation. A
mask was constructed by manually outlining cilia in the image

image taken in the Smo-mEos2 channel, and the fluorescence at
the cilia was measured. Local background correction was
performed by moving the mask to measure fluorescence at a
representative nearby region, and then subtracting this value from
that of ciliary fluorescence. All points represent mean (6SEM)
fluorescence from 10–20 individual cilia. Statistical analysis was
performed using GraphPad Prism software.

Live cell imaging and Photoconversion
NIH 3T3/Smo-mEos2 cells cultured in glass bottom dishes (In
Vitro Scientific, Sunnyvale, CA, USA) were grown to reach
confluence. The cells were then shifted to 0.5% serum medium
and incubated 24 h with SAG or other chemicals as described
before imaging. As described previously (Yu et al., 2011), imaging
of live cells was performed with a Zeiss LSM510 Meta inverted
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taken in the Smo-mEos2N channel before photoconversion and in
the Smo-mEos2P channel after photoconversion. This mask was
then applied to the image taken in the Smo-mEos2P channel
before photoconversion and in the Smo-mEos2N channel after
photoconversion, respectively. The fluorescence at the cilia at
different time points was measured. Local background correction
was performed by moving the mask to measure fluorescence at a
representative nearby region, and then subtracting this value from
that of ciliary fluorescence. All points represent mean (SEM)
fluorescence from 4–5 individual cilia. Statistical analysis was
performed using GraphPad Prism software.

Figure S6 Ciliary accumulation of Smo-mEos2 upon
treatment with inhibitory concentrations of cyclopamine, but not KAAD-cyclopamine. NIH 3T3/Smo-mEos2
cells were incubated with medium containing 3 mM of cyclopamine (A) or 300 nM of KAAD-cyclopamine (B) for 24 h followed
by fixation, antibody staining, and imaging. The boxed region in
each main panel was viewed on the right in separated red, green
channels, and shifted overlays. Scale bar, 5 mm.
(EPS)
Figure S7 KAAD-cyclopamine blocks SAG induced accumulation of endogenous Smo in cilia. (Top) Schematic
diagram of drug treatment, fixation, and staining of NIH 3T3
cells. (A–C) NIH 3T3 cells were incubated with medium
containing DMSO, SAG, or SAG followed by 300 nM of
KAAD-cyclopamine before fixation, antibody staining, and
imaging. Addition of KAAD-cyclopamine inhibits accumulation
of Smo in cilia of cells induced by SAG (compare C to B). The
boxed region in each main panel was viewed on the right in
separated red, green channels, and shifted overlays. Scale bar,
5 mm.
(EPS)

Supporting Information
Figure S1 Smo-mEos2 shows normal function upon

introduction into Smo2/2 cells. Smo2/2 cells were transiently transfected with Smo-mEos2, Gli-luciferase reporter, and
control SV40-Renilla luciferase. Following transfection, cells were
grown to confluency, incubated with ShhN, and assayed for
reporter activity. Error bars indicate SD, n = 3.
(EPS)
Figure S2 Monitoring ciliary entry and exit of SmomEos2 in SAG-treated cells. (A) Schematic diagram of drug
treatment and photoconversion of NIH 3T3/Smo-mEos2 cells. (B)
Time-lapse images taken at 75-second intervals showing both
Smo-mEos2N (green) and Smo-mEos2P (red) from a representative
cilium before and after photoconversion at 405 nm. Scale bar,
1 mm.
(EPS)

Figure S8 Cycloheximide chase experiments to measure the half-life of Smo-mEos2 in cells treated with SAG
followed by additional KAAD-cyclopamine. (A) Schematic
diagram of drug treatment and immunoblotting of NIH 3T3/
Smo-mEos2 cells. (B) NIH 3T3/Smo-mEos2 cells were induced
with SAG for 24 h before the addition of DMSO (upper panel) or
KAAD-cyclopamine (lower panel) together with cycloheximide in
the continued presence of SAG to block protein synthesis for the
indicated periods of time. The level of total Smo-mEos2 was
measured by immunoblotting. (C) Quantification of normalized
(by beta-tubulin) Smo-mEos2 protein levels from cells treated by
DMSO or KAAD-cyclopamine with cycloheximide for the
indicated periods of time.
(EPS)

Figure S3 Cycloheximide chase experiments to measure the half-life of total Smo-mEos2 protein in cells
treated with SAG. (A) NIH 3T3/Smo-mEos2 cells were
induced with (right panel) or without (left panel) SAG for 24 h
before the addition of cycloheximide (right panel, in the continued
presence of SAG) to block protein synthesis for the indicated
periods of time. The level of total Smo-mEos2 was measured by
immunoblotting. (B) Quantification of normalized (by betatubulin) Smo-mEos2 protein levels from cells treated with
cycloheximide for the indicated periods of time.
(EPS)

Figure S9 KAAD-cyclopamine blocks the ciliary accumulation of Smo-mEos2 triggered by CBA. (Top) Schematic diagram of drug treatment, fixation, and staining of NIH
3T3/Smo-mEos2 cells. (A–D) NIH 3T3/Smo-mEos2 cells were
incubated with medium containing DMSO (control), CBA,
KAAD-cyclopamine, or a combination of CBA and KAADcyclopamine for 24 h followed by fixation, antibody staining, and
imaging. The boxed region in each main panel was viewed on the
right in separated red, green channels, and shifted overlays. Scale
bar, 5 mm.
(EPS)

Figure S4 Smo accumulated in primary cilia of cells

treated with CBA. (A–B) NIH 3T3/Smo-mEos2 cells were
incubated in the absence or presence of CBA for 24 h, and then
fixed and stained with anti-acetylated tubulin (primary cilium, red)
and DAPI (nucleus, blue). Smo-mEos2 was detected in the
primary cilium only when the cells were treated with 10 mM CBA
(B), but not in the un-treated cells (A). The boxed region in each
main panel was viewed on the right in separated red, green
channels, and shifted overlays. Scale bar, 5 mm. (C) Quantification
of the percentage of ciliated cells 24 h after treatment with either
CBA or SAG. (D) Quantification of the percentage of cilium with
Smo-mEos2 24 h after treatment with either CBA or SAG.
(EPS)
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